JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.58 CNY | +1.78% |
|
-1.02% | +1.21% |
| May. 28 | China Approves Joincare Unit's Asthma Drug | MT |
| Apr. 25 | Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2024 * | 17.3B 2.39B | Sales 2025 * | 18.83B 2.6B | Capitalization | 23.48B 3.24B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.54B 212M | Net income 2025 * | 1.75B 241M | EV / Sales 2024 * | 1.36 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.25 x |
| P/E ratio 2024 * |
15.3
x | P/E ratio 2025 * |
13.4
x | Employees | 14,365 |
| Yield 2024 * |
1.47% | Yield 2025 * |
1.67% | Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.78% | ||
| 1 week | -1.02% | ||
| Current month | +0.88% | ||
| 1 month | +3.54% | ||
| 3 months | +4.40% | ||
| 6 months | -0.40% | ||
| Current year | +1.21% |
1 week
12.25
12.71
1 month
12.2513.25
Current year
9.7013.25
1 year
9.7013.80
3 years
9.7015.03
5 years
7.5122.47
10 years
4.8530.02
| Managers | Title | Age | Since |
|---|---|---|---|
Xiong Yu
PSD | President | 63 | 21-08-26 |
Qing Feng Qiu
DFI | Director of Finance/CFO | 53 | 12-08-27 |
Zhi Wei Xing
BRD | Director/Board Member | 38 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bao Guo Zhu
FOU | Founder | 62 | 92-12-17 |
Guang Xia Liu
BRD | Director/Board Member | 55 | 12-08-27 |
Qing Feng Qiu
DFI | Director of Finance/CFO | 53 | 12-08-27 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.36% | 2 M€ | -17.32% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-04 | 12.58 | +1.78% | 11,048,870 |
| 24-06-03 | 12.36 | -0.88% | 10,695,620 |
| 24-05-31 | 12.47 | -0.40% | 8,543,421 |
| 24-05-30 | 12.52 | +0.24% | 6,691,009 |
| 24-05-29 | 12.49 | -0.16% | 6,351,194 |
End-of-day quote Shanghai S.E., June 03, 2024
More quotes
Joincare Pharmaceutical Group Industry Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals and healthcare products. The Company's products include chemical materials and intermediates, chemical agents, health products, traditional Chinese medicines, diagnostic reagents and equipment. The Company is also engaged in electricity business. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-06-07
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.58
CNY
Average target price
14.7
CNY
Spread / Average Target
+16.85%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +1.21% | 3.19B | |
| +42.83% | 748B | |
| +34.11% | 598B | |
| -5.70% | 356B | |
| +18.06% | 325B | |
| +4.63% | 283B | |
| +17.02% | 245B | |
| +9.26% | 211B | |
| -4.21% | 209B | |
| +2.43% | 166B |
- Stock Market
- Equities
- 600380 Stock
